A comparative trial of praziquantel, metrifonate and niridazole against Schistosoma haematobium
- PMID: 6882062
- DOI: 10.1080/00034983.1983.11811688
A comparative trial of praziquantel, metrifonate and niridazole against Schistosoma haematobium
Abstract
Praziquantel administered in a single oral dose of 30 mg kg-1 to subjects infected with Schistosoma haematobium produced minimal side effects and was more effective than established regimes of niridazole and metrifonate. Praziquantel should prove a major tool in schistosomiasis control programmes.